0001654954-23-009402.txt : 20230719
0001654954-23-009402.hdr.sgml : 20230719
20230719160332
ACCESSION NUMBER: 0001654954-23-009402
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230717
FILED AS OF DATE: 20230719
DATE AS OF CHANGE: 20230719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SPINK KENNETH B.
CENTRAL INDEX KEY: 0001652627
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22893
FILM NUMBER: 231096715
MAIL ADDRESS:
STREET 1: C/O AEHR TEST SYSTEMS
STREET 2: 400 KATO TERRACE
CITY: FREMONT
STATE: CA
ZIP: 94539
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AEHR TEST SYSTEMS
CENTRAL INDEX KEY: 0001040470
STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825]
IRS NUMBER: 942424084
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 KATO TERRACE
CITY: FREMONT
STATE: CA
ZIP: 94539
BUSINESS PHONE: 5106239400
MAIL ADDRESS:
STREET 1: 400 KATO TERRACE
CITY: FREMONT
STATE: CA
ZIP: 94539
4
1
section16.xml
PRIMARY DOCUMENT
X0508
4
2023-07-17
0001040470
AEHR TEST SYSTEMS
AEHR
0001652627
SPINK KENNETH B.
C/O AEHR TEST SYSTEMS
400 KATO TERRACE
FREMONT
CA
94539
true
VP of Finance and CFO
false
Common Stock
2023-07-17
4
M
false
11511
2.4000
A
11511
D
Common Stock
2023-07-17
4
M
false
25000
1.6350
A
36511
D
Common Stock
2023-07-17
4
S
false
36511
51.3949
D
0
D
Common Stock
109866
I
by Trust
Incentive Stock Option (right to buy)
1.6350
2023-07-17
4
M
false
25000
0
D
2019-08-16
2026-07-16
Common Stock
25000
0
D
Incentive Stock Option (right to buy)
2.4
2023-07-17
4
M
false
11511
0
D
2018-09-17
2025-08-17
Common Stock
11511
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.25 to $51.75, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
The amount reported includes shares subject to unvested restricted stock units.
One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.
/s/ Kenneth B. Spink
2023-07-19